Arcturus Therapeutics Holdings Inc.
ARCT
$10.53
$0.232.23%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -334.67% | 59.90% | 35.80% | -129.07% | 27.83% |
| Total Depreciation and Amortization | -10.20% | 0.33% | 0.55% | 10.92% | -1.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.12% | -1.19% | -3.24% | 15.04% | -4.17% |
| Change in Net Operating Assets | 173.14% | -16.16% | -331.49% | 605.46% | 105.52% |
| Cash from Operations | 98.80% | 21.16% | -442.41% | -783.47% | 98.06% |
| Capital Expenditure | 100.00% | 75.61% | -36.67% | 72.57% | 10.81% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 75.61% | -36.67% | 72.57% | 10.81% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -80.66% | -71.16% | 9.83% | 62.92% | -27.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -80.66% | -71.16% | 9.83% | 111.73% | -185.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 99.35% | 17.52% | -677.69% | 82.10% | -74.60% |